SRX-246, formerly known as API-246, is a vasopressin (AVP) V1a antagonist potentially for treatment of intermittent explosive disorder. References: Fabio KM, Guillon CD, Lu SF, Heindel ND, Brownstein MJ, Lacey CJ, Garippa C, Simon NG. Pharmacokinetics and metabolism of SRX246: a potent and selective vasopressin 1a antagonist. J Pharm Sci. 2013 Jun;102(6):2033-43. doi: 10.1002/jps.23495. Epub 2013 Mar 7. PubMed PMID: 23471831.

纯度：≥98%

CAS：512784-93-9